News Posts List
FDA: Cancer Risk, New-Onset Psoriasis Warning Required for All TNF Blockers
08/08/2009
Malignancies such as leiomyosarcoma, hepatic malignancies, and renal cell carcinoma were also reported.
Tivozanib (AV-951)
08/07/2009
Interim tivozanib Phase 2 data presented by AVEO at the 2009 Genitourinary Symposium (ASCO GU) in February 2009 showed a disease control rate of greater than 90 percent, plus excellent tolerability, in patients with advanced renal cell carcinoma (RCC).
The importance of private-sector pharmaceutical research
08/07/2009
There is a second world of drug research, a world in which patents do not exist and for-profit research is permanently moribund. Its history should stop reformers in their tracks.
France Fights Universal Care's High Cost
08/07/2009
In recent months, France imposed American-style "co-pays" on patients to try to throttle back prescription-drug costs and forced state hospitals to crack down on expenses.
KCA director serves on Defense Dept. review panel
08/06/2009
As a consumer reviewer, she was a full voting member of the scientific peer review panel, along with prominent scientists and clinicians.
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
08/06/2009
Former AMS counselor sees one of her dreams come true
08/06/2009
Kidney cancer survivor, Ann Marie Della Fera records CD, with donations being donated to the Kidney Cancer Association.